These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 23340885)
21. The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis. Liu Q; Liu Z Gynecol Endocrinol; 2022 Jun; 38(6):450-454. PubMed ID: 35575290 [TBL] [Abstract][Full Text] [Related]
22. Myo-inositol supplementation for prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis. Mashayekh-Amiri S; Mohammad-Alizadeh-Charandabi S; Abdolalipour S; Mirghafourvand M Diabetol Metab Syndr; 2022 Jul; 14(1):93. PubMed ID: 35794663 [TBL] [Abstract][Full Text] [Related]
23. [Study on weight gain in different stages of pregnancy and pregnancy outcomes]. Chen XL; Peng YY; Xu XQ Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1493-1497. PubMed ID: 29804417 [No Abstract] [Full Text] [Related]
24. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial. Asimakopoulos G; Pergialiotis V; Antsaklis P; Theodora M; Loutradis D; Daskalakis G Arch Gynecol Obstet; 2024 Oct; 310(4):1895-1903. PubMed ID: 39141124 [TBL] [Abstract][Full Text] [Related]
25. The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study. Mashayekh-Amiri S; Delavar MA; Bakouei F; Faramarzi M; Esmaeilzadeh S J Matern Fetal Neonatal Med; 2022 Sep; 35(18):3415-3423. PubMed ID: 32933356 [TBL] [Abstract][Full Text] [Related]
27. Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results. Dell'Edera D; Sarlo F; Allegretti A; Epifania AA; Simone F; Lupo MG; Benedetto M; D'Apice MR; Capalbo A Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3305-3311. PubMed ID: 28770950 [TBL] [Abstract][Full Text] [Related]
28. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Farren M; Daly N; McKeating A; Kinsley B; Turner MJ; Daly S Diabetes Care; 2017 Jun; 40(6):759-763. PubMed ID: 28325784 [TBL] [Abstract][Full Text] [Related]
29. Inositol supplementation for the prevention and treatment of gestational diabetes mellitus: a meta-analysis of randomized controlled trials. Li C; Shi H Arch Gynecol Obstet; 2024 May; 309(5):1959-1969. PubMed ID: 37308791 [TBL] [Abstract][Full Text] [Related]
31. Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case. Costabile L; Unfer V Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):73-76. PubMed ID: 28724184 [TBL] [Abstract][Full Text] [Related]
32. Myo-inositol supplementation for the prevention of gestational diabetes: A meta-analysis of randomized controlled trials. Li L; Fang J Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():38-43. PubMed ID: 35460931 [TBL] [Abstract][Full Text] [Related]
33. Comparison of adverse pregnancy outcomes based on the new IADPSG 2010 gestational diabetes criteria and maternal body mass index. Jiang S; Chipps D; Cheung WN; Mongelli M Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):533-539. PubMed ID: 28421604 [TBL] [Abstract][Full Text] [Related]
34. Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Wei J; Yan J; Yang H Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889788 [TBL] [Abstract][Full Text] [Related]
35. Perinatal outcomes for untreated women with gestational diabetes by IADPSG criteria: a population-based study. Shah BR; Sharifi F BJOG; 2020 Jan; 127(1):116-122. PubMed ID: 31553136 [TBL] [Abstract][Full Text] [Related]
36. Influence of myo-inositol on metabolic status for gestational diabetes: a meta-analysis of randomized controlled trials. Chen H; Xiong J; Li Z; Chen Y; Zhang M; Chen D; Liu B J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2228450. PubMed ID: 39115013 [TBL] [Abstract][Full Text] [Related]
37. Pregnancy Outcomes of Women Additionally Diagnosed as Gestational Diabetes by the International Association of the Diabetes and Pregnancy Study Groups Criteria. Kim MH; Kwak SH; Kim SH; Hong JS; Chung HR; Choi SH; Kim MY; Jang HC Diabetes Metab J; 2019 Dec; 43(6):766-775. PubMed ID: 30877713 [TBL] [Abstract][Full Text] [Related]
38. Myo-inositol may prevent gestational diabetes in PCOS women. D'Anna R; Di Benedetto V; Rizzo P; Raffone E; Interdonato ML; Corrado F; Di Benedetto A Gynecol Endocrinol; 2012 Jun; 28(6):440-2. PubMed ID: 22122627 [TBL] [Abstract][Full Text] [Related]
39. Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis. Zheng X; Liu Z; Zhang Y; Lin Y; Song J; Zheng L; Lin S Medicine (Baltimore); 2015 Oct; 94(42):e1604. PubMed ID: 26496267 [TBL] [Abstract][Full Text] [Related]
40. Non-pharmacological management of gestational diabetes: The role of myo-inositol. Guardo FD; Currò JM; Valenti G; Rossetti P; Di Gregorio LM; Conway F; Chiofalo B; Garzon S; Bruni S; Rizzo G J Complement Integr Med; 2019 Sep; 17(2):. PubMed ID: 31527297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]